Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Oxymorphazone: a long-acting opiate analgesic.

G S Ling, S Galetta, G W Pasternak

    Cellular and Molecular Neurobiology
    |March 1, 1984
    PubMed
    Summary

    Oxymorphazone, a novel opioid derivative, demonstrates long-lasting analgesia by persistently inhibiting opioid binding in the brain. This effect, observed both in vitro and in vivo, suggests a unique mechanism of action for sustained pain relief.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Serial Imaging of Virus-Associated Necrotizing Disseminated Acute Leukoencephalopathy (VANDAL) in COVID-19.

    AJNR. American journal of neuroradiology·2020
    Same author

    Break in binocular fusion during head turning in MS patients with INO.

    Neurology·2008
    Same author

    Stiff eyes in stiff-person syndrome.

    Neurology·2008
    Same author

    Pearls & Oy-sters: The medial longitudinal fasciculus in ocular motor physiology.

    Neurology·2008
    Same author

    Clinical reasoning: a 59-year-old woman with acute paraplegia.

    Neurology·2007
    Same author

    NPY-induced feeding: pharmacological characterization using selective opioid antagonists and antisense probes in rats.

    Peptides·2005

    Area of Science:

    • Pharmacology
    • Neuroscience
    • Medicinal Chemistry

    Background:

    • Opioid analgesics are crucial for pain management.
    • Understanding novel opioid derivatives' mechanisms is essential for developing improved therapeutics.
    • Oxymorphone derivatives offer potential for unique pharmacological profiles.

    Purpose of the Study:

    • To investigate the in vitro and in vivo effects of oxymorphazone, a hydrazone derivative of oxymorphone.
    • To characterize the binding inhibition and analgesic properties of oxymorphazone.
    • To compare the duration and potency of oxymorphazone with oxymorphone.

    Main Methods:

    • In vitro inhibition assays using rat brain homogenates and radiolabeled opioids.
    • In vivo analgesia studies in mice using tail-flick assay after systemic and intracerebroventricular administration.
    • Dose-response and time-course analyses of analgesic effects.

    Main Results:

    • Oxymorphazone selectively and persistently inhibited high-affinity mu 1 opioid binding in vitro, unaffected by washing.
    • In vivo administration of oxymorphazone resulted in dose-dependent, long-lasting analgesia, exceeding that of oxymorphone.
    • Oxymorphazone exhibited greater potency via intracerebroventricular administration compared to systemic routes.

    Conclusions:

    • Oxymorphazone possesses a unique, long-acting inhibitory effect on opioid binding, leading to prolonged analgesia.
    • The persistent analgesic action of oxymorphazone may involve mechanisms beyond typical opioid pharmacokinetics.
    • Further research into oxymorphazone's mechanism is warranted for potential therapeutic applications.

    Related Experiment Videos